Form 6-K CHINA LIFE INSURANCE CO For: Jul 06
Commission File Number 001-31914
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
July 6, 2015
China Life Insurance Company Limited
(Translation of registrants name into English)
16 Financial Street
Xicheng District
Beijing 100033, China
Tel: (86-10) 6363-3333
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes ¨ No x
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-
Commission File Number 001-31914
China Life Insurance Company Limited issued an announcement on July 3, 2015, a copy of which is attached as Exhibit 99.1 hereto.
EXHIBIT LIST
Exhibit | Description | |
99.1 | Announcement, dated July 3, 2015 |
Commission File Number 001-31914
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
China Life Insurance Company Limited | ||||||
(Registrant) | ||||||
By: | /s/ Lin Dairen | |||||
(Signature) | ||||||
July 3, 2015 | Name: | Lin Dairen | ||||
Title: | President and Executive Director |
Exhibit 99.1
Commission File Number 001-31914
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities. Nothing in this announcement constitutes an offer of securities for sale in the United States or any other jurisdiction where it is unlawful to do so. The securities have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or the securities laws of any other place. Accordingly, the securities may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities may be offered and sold only in offshore transactions in reliance on Regulation S under the Securities Act (Regulation S), and in each case, in accordance with any other applicable law.
There will be no public offering of securities in the United States. Any public offering of securities to be made in the United States will be made by means of a prospectus. Such prospectus will contain detailed information about the company making the offer and its management and financial statements.
NOTICE OF LISTING ON
THE STOCK EXCHANGE OF HONG KONG LIMITED
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability)
(Stock Code: 2628)
US$1,280,000,000 CORE TIER 2 CAPITAL SECURITIES
(Stock Code: 5540)
Joint Global Coordinators
(in alphabetical order)
BNP PARIBAS | Citigroup | HSBC | ||
Joint Bookrunners and Joint Lead
Managers
| ||||
BNP PARIBAS | BofA Merrill Lynch | China International Capital Corporation Hong Kong Securities Limited
| ||
Citigroup | Goldman Sachs (Asia) L.L.C. | HSBC |
Commission File Number 001-31914
Application has been made to The Stock Exchange of Hong Kong Limited for the listing of, and permission to deal in, the US$1,280,000,000 Core Tier 2 Capital Securities at an initial distribution rate of 4.00% (the Securities) to be issued by China Life Insurance Company Limited (the Company) by way of debt issues to professional investors only as described in the offering circular relating thereto dated 25 June 2015. Permission for the listing of, and dealing in, the Securities is expected to become effective on 6 July 2015.
By Order of the Board China Life Insurance Company Limited Heng Victor Ja Wei Company Secretary |
Hong Kong, 3 July 2015
As at the date of this announcement, the board of directors of the Company comprises:
Executive Directors: | Yang Mingsheng, Lin Dairen, Xu Hengping*, Xu Haifeng* | |
Non-executive Directors: | Miao Jianmin, Zhang Xiangxian, Wang Sidong, Liu Jiade* | |
Independent Non-executive Directors: | Anthony Francis Neoh, Chang Tso Tung Stephen, Huang Yiping, Drake Pike* |
*Note: | The qualification of each of Mr. Xu Hengping, Mr. Xu Haifeng, Mr. Liu Jiade and Mr. Drake Pike as a Director is still subject to the approval of the China Insurance Regulatory Commission. |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ether Capital Corporation Reports 2023 Q4 and Annual Financial Results
- Trending and Breaking the Grounds of the Digital Economy: BlockDAG Network
- Apple in talks with Google to use generative AI in iPhones- Bloomberg
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!